{"eventGroups":[{"description":"All patients that received Basiliximab 20 mg monoclonal therapy","id":"EG000","otherNumAffected":0,"otherNumAtRisk":10,"seriousNumAffected":4,"seriousNumAtRisk":10,"title":"Basiliximab 20 mg"}],"frequencyThreshold":"0","seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"GvHD","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":10,"numEvents":4}],"term":"GvHD"}]}